Intensive care medicine
-
Intensive care medicine · Apr 2024
Multicenter Study Observational StudyLong-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.
Patients with hematologic malignancy (HM) commonly develop critical illness. Their long-term survival and functional outcomes have not been well described. ⋯ 49% of all HM patients were alive at 7 days post-ICU discharge, and 21% at 12 months. Survival varied based upon hematologic diagnosis and frailty status. Survivors had important functional disability and impairment in emotional, physical, and general well-being.